|
CL2025003637A1
(es)
|
|
Anticuerpos anti-tgf-beta 1 latente y métodos de uso.
|
|
BR102022025291A2
(https=)
|
|
|
|
BR102023014872A2
(https=)
|
|
|
|
BR102023012440A2
(https=)
|
|
|
|
BR102023010976A2
(https=)
|
|
|
|
BR102023009641A2
(https=)
|
|
|
|
BR102023008688A2
(https=)
|
|
|
|
BR102023007252A2
(https=)
|
|
|
|
BR102023005164A2
(https=)
|
|
|
|
BR102023001877A2
(https=)
|
|
|
|
BR102023000289A2
(https=)
|
|
|
|
BR102022026909A2
(https=)
|
|
|
|
BR102022023461A2
(https=)
|
|
|
|
BY13175U
(https=)
|
|
|
|
CN307047773S
(https=)
|
|
|
|
BY13172U
(https=)
|
|
|
|
BY13170U
(https=)
|
|
|
|
BY13159U
(https=)
|
|
|
|
BY13169U
(https=)
|
|
|
|
BY13168U
(https=)
|
|
|
|
BY13166U
(https=)
|
|
|
|
CN307048186S
(https=)
|
|
|
|
BY13165U
(https=)
|
|
|
|
BY13164U
(https=)
|
|
|
|
BY13163U
(https=)
|
|
|